Cargando…
Evaluation of treatment of invasive fungal infections
OBJECTIVE: To identify the risk factors associated with invasive fungal infections (IFI) in immunocompromised patients (IP), and monitor antifungal therapy appropriateness and costs. MATERIALS AND METHODS: The 1-year observational retrospective study was performed on 101 IP, who received antifungal...
Autores principales: | Casucci, Ilenia, Provenzani, Alessio, Polidori, Piera |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3917166/ https://www.ncbi.nlm.nih.gov/pubmed/24554910 http://dx.doi.org/10.4103/0976-500X.124423 |
Ejemplares similares
-
Covid-19 and drug therapy, what we learned
por: Provenzani, Alessio, et al.
Publicado: (2020) -
Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay
por: Di Martino, Enrica, et al.
Publicado: (2020) -
Anidulafungin in the treatment of invasive fungal infections
por: Sabol, Kathryn, et al.
Publicado: (2008) -
Evaluation of Hepatotoxicity with Treatment Doses of Flucytosine and Amphotericin B for Invasive Fungal Infections
por: Folk, Alexandra, et al.
Publicado: (2016) -
Micafungin for the treatment of pediatric invasive fungal infections
por: Arrieta, A, et al.
Publicado: (2009)